Literature DB >> 33301426

Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models.

Xiaoxiao He1, Jiangbo Wan2, Xiaona Yang3, Xiuze Zhang4, Dan Huang1, Xie Li4, Yejun Zou4, Chiqi Chen1, Zhuo Yu1, Li Xie1, Yaping Zhang1, Ligen Liu1, Shangang Li5, Yuzheng Zhao4, Hongfang Shao6, Ye Yu3, Junke Zheng1,7.   

Abstract

How particular bone marrow niche factors contribute to the leukemogenic activities of leukemia-initiating cells (LICs) remains largely unknown. Here, we showed that ATP levels were markedly increased in the bone marrow niches of mice with acute myeloid leukemia (AML), and LICs preferentially localized to the endosteal niche with relatively high ATP levels, as indicated by a sensitive ATP indicator. ATP could efficiently induce the influx of ions into LICs in an MLL-AF9-induced murine AML model via the ligand-gated ion channel P2X7. P2x7 deletion led to notably impaired homing and self-renewal capacities of LICs and contributed to an approximately 5-fold decrease in the number of functional LICs but had no effect on normal hematopoiesis. ATP/P2X7 signaling enhanced the calcium flux-mediated phosphorylation of CREB, which further transactivated phosphoglycerate dehydrogenase (Phgdh) expression to maintain serine metabolism and LIC fates. P2X7 knockdown resulted in a markedly extended survival of recipients transplanted with either human AML cell lines or primary leukemia cells. Blockade of ATP/P2X7 signaling could efficiently inhibit leukemogenesis. Here, we provide a perspective for understanding how ATP/P2X7 signaling sustains LIC activities, which may benefit the development of specific strategies for targeting LICs or other types of cancer stem cells.

Entities:  

Keywords:  Hematology; Leukemias; Stem cells

Year:  2021        PMID: 33301426      PMCID: PMC7880412          DOI: 10.1172/JCI140242

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

Review 1.  Pharmacology of cloned P2X receptors.

Authors:  R A North; A Surprenant
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP.

Authors:  A Casati; M Frascoli; E Traggiai; M Proietti; U Schenk; F Grassi
Journal:  Cell Death Differ       Date:  2010-08-27       Impact factor: 15.828

3.  Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts.

Authors:  Ying Liu; Yue-Hang Geng; Hui Yang; Han Yang; Yan-Ting Zhou; Hong-Quan Zhang; Xin-Xia Tian; Wei-Gang Fang
Journal:  Cancer Lett       Date:  2018-05-05       Impact factor: 8.679

4.  Expression of P2X7 receptor increases in vivo tumor growth.

Authors:  Elena Adinolfi; Lizzia Raffaghello; Anna Lisa Giuliani; Luigi Cavazzini; Marina Capece; Paola Chiozzi; Giovanna Bianchi; Guido Kroemer; Vito Pistoia; Francesco Di Virgilio
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

5.  The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma.

Authors:  F Amoroso; M Capece; A Rotondo; D Cangelosi; M Ferracin; A Franceschini; L Raffaghello; V Pistoia; L Varesio; E Adinolfi
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

6.  Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.

Authors:  Mélanie Bruchard; Grégoire Mignot; Valentin Derangère; Fanny Chalmin; Angélique Chevriaux; Frédérique Végran; Wilfrid Boireau; Benoit Simon; Bernhard Ryffel; Jean Louis Connat; Jean Kanellopoulos; François Martin; Cédric Rébé; Lionel Apetoh; François Ghiringhelli
Journal:  Nat Med       Date:  2012-12-02       Impact factor: 53.440

7.  The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment.

Authors:  Helmut Greim; Debra A Kaden; Richard A Larson; Christine M Palermo; Jerry M Rice; David Ross; Robert Snyder
Journal:  Ann N Y Acad Sci       Date:  2014-02-04       Impact factor: 5.691

Review 8.  Extracellular purines, purinergic receptors and tumor growth.

Authors:  F Di Virgilio; E Adinolfi
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

9.  Imaging extracellular ATP with a genetically-encoded, ratiometric fluorescent sensor.

Authors:  Jason M Conley; Saranya Radhakrishnan; Stephen A Valentino; Mathew Tantama
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

10.  A genetically encoded single-wavelength sensor for imaging cytosolic and cell surface ATP.

Authors:  Mark A Lobas; Rongkun Tao; Jun Nagai; Mira T Kronschläger; Philip M Borden; Jonathan S Marvin; Loren L Looger; Baljit S Khakh
Journal:  Nat Commun       Date:  2019-02-12       Impact factor: 14.919

View more
  7 in total

Review 1.  The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia.

Authors:  Anna Pegoraro; Elena Adinolfi
Journal:  Purinergic Signal       Date:  2021-06-01       Impact factor: 3.765

2.  p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress.

Authors:  Lin Tze Tung; HanChen Wang; Jad I Belle; Jessica C Petrov; David Langlais; Anastasia Nijnik
Journal:  Cell Death Dis       Date:  2021-10-08       Impact factor: 8.469

3.  Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation.

Authors:  Valentina Vultaggio-Poma; Simonetta Falzoni; Paola Chiozzi; Alba Clara Sarti; Elena Adinolfi; Anna Lisa Giuliani; Alejandro Sánchez-Melgar; Paola Boldrini; Michele Zanoni; Anna Tesei; Paolo Pinton; Francesco Di Virgilio
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

4.  Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells.

Authors:  Peng-Cheng Yu; Di Liu; Zeng-Xiang Han; Fang Liang; Cui-Yun Hao; Yun-Tao Lei; Chang-Run Guo; Wen-Hui Wang; Xing-Hua Li; Xiao-Na Yang; Chang-Zhu Li; Ye Yu; Ying-Zhe Fan
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

Review 5.  To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.

Authors:  Serena Janho Dit Hreich; Jonathan Benzaquen; Paul Hofman; Valérie Vouret-Craviari
Journal:  Purinergic Signal       Date:  2021-08-04       Impact factor: 3.765

Review 6.  Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies.

Authors:  Livingstone Fultang; Luciana Gneo; Carmela De Santo; Francis J Mussai
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

7.  Quantification of bone marrow interstitial pH and calcium concentration by intravital ratiometric imaging.

Authors:  S-C A Yeh; J Hou; J W Wu; S Yu; Y Zhang; K D Belfield; F D Camargo; C P Lin
Journal:  Nat Commun       Date:  2022-01-19       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.